Alexion Pharmaceuticals, Inc. (ALXN) on Thursday raised its adjusted earnings guidance for the full year 2018 to a range of $7.00 to $7.15 per share from the prior forecast range of $6.75 to $6.90 per share.
from RTT - Earnings https://ift.tt/2v3ZEhq
via IFTTT
No comments:
Post a Comment